Document headings vary by document type but may contain
                    the following: the agency or agencies that issued and signed a document
the number of the CFR title and the number of each part
                      the document amends, proposes to amend, or is directly
                      related to
the agency docket number / agency internal file number
the RIN which identifies each regulatory action listed in
                      the Unified Agenda of Federal Regulatory and Deregulatory
                      Actions See the
                    Document Drafting Handbook
                    for more details.
 Department of Justice [OMB Number 1117-0003]
 AGENCY: Drug Enforcement Administration, Department of Justice.
 ACTION: 30-Day notice.
 SUMMARY: The Department of Justice (DOJ), Drug Enforcement Administration (DEA), will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. The proposed information collection was previously published in the 
                        **Federal Register**
                        , on August 11, 2017, allowing for a 60 day comment period.
 DATES: Comments are encouraged and will be accepted for 30 days until November 13, 2017.
 FOR FURTHER INFORMATION CONTACT: If you have comments on the estimated public burden or associated response time, suggestions, or need a copy of the proposed information collection instrument with instructions or additional information, please contact Michael J. Lewis, Diversion Control Division, Drug Enforcement Administration; Mailing Address: 8701 Morrissette Drive, Springfield, Virginia 22152; Telephone: (202) 598-6812. Written comments and/or suggestions can also be sent to the Office of Management and Budget, Office of Information and Regulatory Affairs, Attention Department of Justice Desk Officer, Washington, DC 20503 or sent to 
                        *OIRA_submission@omb.eop.gov.*


SUPPLEMENTARY INFORMATION: Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address one or more of the following four points: —Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; —Evaluate the accuracy of the agency's estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; —Evaluate whether and if so how the quality, utility, and clarity of the information proposed to be collected can be enhanced; and —Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other forms of information technology, 
                    *e.g.,*
                     permitting electronic submission of responses. Overview of This Information Collection 1. 
                    *Type of Information Collection:*
                     Extension of a currently approved collection. 2. 
                    *Title of the Form/Collection:*
                     ARCOS Transaction Reporting. 3. 
                    *The agency form number, if any, and the applicable component of the Department sponsoring the collection:*
                     DEA Form 333. The applicable component within the Department of Justice is the Drug Enforcement Administration, Diversion Control Division.
                    ( print page 47581) 4. 
                    *Affected public who will be asked or required to respond, as well as a brief abstract:* *Affected public:*
                     Business or other for-profit. *Abstract:*
                     Section 307 of the Controlled Substances Act (21 U.S.C. 827) requires controlled substance manufacturers and distributors to make periodic reports to the DEA regarding the sale, delivery, and other disposal of certain controlled substances. These reports help ensure a closed system of distribution for controlled substances, and are used to comply with international treaty obligations. 5. 
                    *An estimate of the total number of respondents and the amount of time estimated for an average respondent to respond:*
                     The below table presents information regarding the number of respondents, responses and associated burden hours. Number of 
                             annual  
                             respondents
Number of 
                             annual  
                             responses
Average time 
                             per response  
                             (hours)
Total annual 
                             hoursDEA-333 (paper)
70
379
1
379DEA-333 (electronic)
1,552
11,777
* 0.1667
1,963Total
1,622
12,156

2,342*10 Minutes.
 6. 
                    *An estimate of the total public burden (in hours) associated with the proposed collection:*
                     The DEA estimates that this collection takes 2,342 annual burden hours. If additional information is required please contact: Melody Braswell, Department Clearance Officer, United States Department of Justice, Justice Management Division, Policy and Planning Staff, Two Constitution Square, 145 N Street NE., Suite 3E.405B, Washington, DC 20530. Dated: October 5, 2017. Melody Braswell, Department Clearance Officer for PRA, U.S. Department of Justice.


[FR Doc. 2017-21966 Filed 10-11-17; 8:45 am] BILLING CODE 4410-09-P